Bloomington-based Indiana University is leading a coalition selected for the National Science Foundation’s Regional Innovation Engines program to accelerate musculoskeletal research and commercialization across Indiana.
The NSF Impact Engine in Indiana will receive $15 million over two years to build a regional innovation ecosystem focused on musculoskeletal conditions, including arthritis, osteoporosis, bone fractures and traumatic injuries. The coalition could receive up to $160 million in NSF funding over the next decade if it meets program milestones, according to a July 14 news release.
Partners include Eli Lilly, Zimmer Biomet, BioCrossroads, OrthoWorx, Indianapolis-based IU Health and Regenstrief Institute, West Lafayette, Ind.-based Purdue University and the University of Notre Dame in Indiana. The initiative aims to connect industry, research and clinical organizations to accelerate development of new therapies, implants, diagnostics and other musculoskeletal technologies.
The coalition also secured $179 million in partner funding and aims to train more than 1,900 workers, launch more than 85 startups, bring at least 30 innovations to market and generate more than $535 million in economic impact. The effort also will support development of what it aims to be the world’s largest integrated musculoskeletal dataset, according to the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.